Skip to Main content Skip to Navigation
Journal articles

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

Mohamed Benchekroun Alejandro Romero Javier Egea Rafael León Patrycja Michalska Izaskun Buendía María Luisa Jimeno Daniel Jun Jana Janockova Vendula Sepsova Ondrej Soukup Oscar Bautista-Aguilera Bernard Refouvelet Olivier Ouari José Marco-Contelles Lhassane Ismaili 1 
1 Laboratoires de neurosciences intégratives et cliniques (EA 481)
Document type :
Journal articles
Complete list of metadata
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03654706
Contributor : Lhassane ISMAILI Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 5:49:04 PM
Last modification on : Friday, August 5, 2022 - 9:24:10 AM

Identifiers

Collections

UNIV-FCOMTE

Citation

Mohamed Benchekroun, Alejandro Romero, Javier Egea, Rafael León, Patrycja Michalska, et al.. The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. Journal of Medicinal Chemistry, American Chemical Society, 2016, 59 (21), pp.9967-9973. ⟨10.1021/acs.jmedchem.6b01178⟩. ⟨hal-03654706⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

9